← Back to Search

Other

Multicultural Healthy Diet for Chronic Kidney Disease

N/A
Recruiting
Research Sponsored by Montefiore Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
CKD stage 3 (estimated glomerular filtration rate (GFR) < 60 - >30 ml/min/1.73m2)
Age ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months post baseline
Awards & highlights

Study Summary

This trial will test whether a diet designed to reduce inflammation is feasible and acceptable for people with kidney disease.

Who is the study for?
This trial is for adults over 18 living in the Bronx who speak English or Spanish and have moderate chronic kidney disease (stage 3). They must be willing to change their diet, not have severe illnesses that would interfere with the study, and cannot have very high potassium levels or poorly controlled diabetes.Check my eligibility
What is being tested?
The study is testing a culturally-tailored anti-inflammatory diet designed specifically for people from diverse backgrounds with chronic kidney disease. It aims to see if participants find this diet manageable and acceptable.See study design
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include digestive adjustments as the body adapts to new foods. Specific side effects will depend on individual health conditions and dietary responses.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My kidney function is moderately reduced.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months post baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months post baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Feasibility of dietary intervention
Other outcome measures
Potassium

Trial Design

1Treatment groups
Experimental Treatment
Group I: All participants will receive the interventionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,314,572 Total Patients Enrolled
Montefiore Medical CenterLead Sponsor
444 Previous Clinical Trials
582,540 Total Patients Enrolled

Media Library

Multicultural Health Diet (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05504850 — N/A
Chronic Kidney Disease Research Study Groups: All participants will receive the intervention
Multicultural Health Diet (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05504850 — N/A
Chronic Kidney Disease Clinical Trial 2023: Multicultural Health Diet Highlights & Side Effects. Trial Name: NCT05504850 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is this research being populated by participants?

"Correct. According to the clinicaltrials.gov database, this research is currently looking for participants which was first uploaded on November 3rd 2022 and updated recently. A total of 20 patients are being sought from one medical centre."

Answered by AI

Is this clinical trial open to participants that are not yet 70 years of age?

"The minimum and maximum ages for enrollment in this medical trial is 18 to 85. There are 43 studies specifically targeting patients below the age of consent, while 457 investigate those over retirement-age."

Answered by AI

Are there any current opportunities to enroll in this trial?

"Clinicaltrials.gov indicates that this trial is still recruiting patients and has been since it was first published in November 3rd 2022, with no changes to the data posted on that day."

Answered by AI

Who is eligible to enroll in this medical experiment?

"This study is actively recruiting 20 participants aged 18 and over, who are suffering from Stage 3 CKD (GFR < 60 - >30 ml/min/1.73m2), live in the Bronx, can speak either English or Spanish as their primary language, and consent to the trial's conditions orally or in writing."

Answered by AI
~8 spots leftby Apr 2025